GIM122 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Maligna
Phase 1/2 · Advanced Solid Malignancies |
Georgiamune Inc | GIM122 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|